Zur Rose Group acquired TeleClinic: the advisors

A group of sellers including IDInvest Partners and Digital Health Ventures have agreed to sell their portfolio company TeleClinic to Zur Rose Group. Headquartered in Munich, the fast-growing tech company, founded in 2015 by Katharina Jünger, has rapidly achieved the status of the leading telemedicine provider in Germany. TeleClinic’s operating parameters and growth demonstrate the vast potential of remote and digital medical services, the global acceptance of which is rapidly expanding as a result of Covid-19 related social distancing constraints.

The advisors

P+P Poellath + Partners and Würtenberger Partnerschaft von Rechtsanwälten acted as legal advisors to Zur Rose. In house strategy was carried out by Chief Strategy and Digital Officer Betul Susamis Unaran.

Guillaume Cavalin as general counsel of IDInvest Partners worked in the operation.